Latest news for Gogox Holdings (OTC:GGHLF) Stock

Gogox Holdings Ltd is an online platform for intra-city logistics services in Asia. The company operates two brands in this space, namely Kuaigou Dache in mainland China and GOGOX in other Asian countries and regions. The company's reportable segments are divided into Chinese mainland operations, and Hong Kong and overseas operations.

Gogox Holdings Ltd

Keefe, Bruyette &amp; Woods analyst Kyle Voigt maintains LPL Finl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPLA#NASDAQ">LPLA</a>) with a Outperform and lowers the price target from $326 to $315.

News

Price Target

Analyst Ratings

LPLA

Keefe, Bruyette & Woods Maintains Outperform on LPL Finl Hldgs, Lowers Price Target to $315

<ul>
<li>Multikine, a true first-line cancer immunotherapy, cut the 5-year risk of death by half compared to control in its target population</li>
<li>Bias analysis conducted in preparation for submission of data to regulatory agencies including the FDA for confirmatory registration study</li>
<li>Detailed data on parameters including patient age, sex, race, tumor locations, and staging demonstrate balance between the treatment and control arms, no bias found, supporting confidence in Multikine's efficacy results</li>
</ul>
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcel-sci.com%2F&amp;esheet=54100013&amp;newsitemid=20240726306579&amp;lan=en-US&amp;anchor=CEL-SCI+Corporation&amp;index=1&amp;md5=82d04ea8b620a5747c364cfd27dacc10">CEL-SCI Corporation</a> (NYSE:<a href="https://www.benzinga.com/stock/CVM#NYSE">CVM</a>) today reported positive results from a bias analysis conducted for its concluded Phase 3 study of Multikine (Leukocyte Interleukin, Injection)&#x2A; in the treatment of head and neck cancer. Conducting a bias analysis is a standard process used to identify, assess, and address potential sources of bias that could influence the outcomes and interpretations of study results. The goal of a bias analysis is to ensure that the trial's findings are reliable, the conclusions are valid, and to minimize the risk that bias has distorted the results.

Biotech

General

CEL-SCI's Phase 3 Population Analysis For Confirmatory Registration Study In Head & Neck Cancer Demonstrates Well Balanced Patient Population, Confidence In Clinical Results; Multikine, A Cancer Immunotherapy, Cut The 5-Year Risk Of Death By Half Compared To Control In Its Target Population

Floki's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">FLOKI</a>) recent Bitstamp listing has traders optimistic about the <a href="https://www.benzinga.com/money/floki-price-prediction">meme coin&#8217;s near future</a>.
What Happened: Floki officially <a href="https://x.com/RealFlokiInu/status/1816496896413745558">announced</a> that it is now live on Bitstamp, the oldest and largest running cryptocurrency exchange in Europe. The two pairs that will be listed are FLOKI/EUR and FLOKI/USD and will be available for fee-free trading for the first month. Recently acquired by retail trading platform Robinhood, the exchange has 50 licenses and registrations in key jurisdictions globally.
Crypto traders <a href="https://x.com/XMaximist/status/1816782024184639825">reacted</a> with optimism, with one stating it is a huge win for Floki, as it is among the few meme coins listed on Bitstamp.
Another trader <a href="https://x.com/CryptoNewton/status/1816555500923679191">noted</a> that Floki is well-positioned compared to Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>), Dogwifhat (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">WIF</a>), and Bonk (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">BONK</a>) when the market rebounds again for meme coins. 
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/"><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/27091545/Benzinga-conference.gif" alt="Benzinga future of digital assets conference" class="wp-image-267246" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39893280/top-crypto-trader-shares-his-5-meme-coin-portfolio-picks-terms-one-the-doge-of-this-cycle">Top Crypto Trader Shares His 5 Meme Coin Portfolio Picks, Terms One &#8216;The DOGE Of This Cycle&#8217;</a>
Why It Matters: Floki is the sixth-largest meme coin according to Coingecko <a href="https://www.coingecko.com/en/categories/meme-token">data</a>. It is up 4% over the past 30 days, outperforming Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) and Pepe, which are down 4% each.
Crypto trader Posty, in his latest <a href="https://x.com/PostyXBT/status/1816442637991194655">X</a> post, thinks &#8220;the up-only trend&#8221; can resume for Floki.
Heavily followed trader Crypto Scofield <a href="https://x.com/Crypto_Scofield/status/1816770198579351736">highlighted</a> that dog meme coins look strong and thinks Floki is "performing well and is poised to follow Dogecoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) movements, as it typically acts as Doge's beta."
He highlighted that Floki has indicated strength over time and it has strong fundamentals and upcoming catalysts to be announced soon.
Another crypto trader expects an uptrend soon:
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Trend -&gt; Consolidate -&gt; Trend<a href="https://twitter.com/search?q=%24FLOKI&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$FLOKI</a> <a href="https://t.co/nc1Sh0XV1L">https://t.co/nc1Sh0XV1L</a> <a href="https://t.co/gPXmM4fv8j">pic.twitter.com/gPXmM4fv8j</a>
&mdash; Chimp of the North (@cryptochimpanz) <a href="https://twitter.com/cryptochimpanz/status/1816719697011691732?ref_src=twsrc%5Etfw">July 26, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
What&#8217;s Next: The influence of meme coins is expected to be thoroughly explored at Benzinga&#8217;s upcoming <a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a> event on Nov. 19. Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39668969/this-dog-coin-is-entering-a-zone-of-very-attractive-valuations-says-trader-and-its-not-shi">This Dog Coin Is Entering A Zone Of &#8216;Very Attractive Valuations,&#8217; Says Trader&#8230;And It&#8217;s Not SHIB, DOGE</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BONK

$DOGE

$FLOKI

$PEPE

$SHIB

$WIF

Floki Listed On Bitstamp, 'Poised To Follow Dogecoin's Movements,' States Trader

RBC Capital analyst Michael Harvey reiterates Veren (TSX:<a class="ticker" href="https://www.benzinga.com/stock/VRN#TSX">VRN</a>) with a Outperform and maintains C$13 price target.

Reiteration

TSX:VRN

RBC Capital Reiterates Outperform on Veren, Maintains C$13 Price Target

Premier Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFC#NASDAQ">PFC</a>) reported quarterly earnings of $0.45 per share which missed the analyst consensus estimate of $0.51 by 11.76 percent. This is a 33.82 percent decrease over earnings of $0.68 per share from the same period last year. The company reported quarterly sales of $49.23 million which missed the analyst consensus estimate of $56.63 million by 13.08 percent. This is a 8.83 percent decrease over sales of $53.99 million the same period last year.

Earnings

Premier Financial Q2 EPS $0.45 Misses $0.51 Estimate, Sales $49.23M Miss $56.63M Estimate

CREV: 136% &#x7C; <a href="https://www.benzinga.com//node/39976837">Reported Earlier, Carbon Revolution Teams Up With GM Providing Carbon Fiber Wheels For Chevrolet Corvette ZR1</a>
&nbsp;
WINT: 131% &#x7C; <a href="https://www.benzinga.com//node/39979111">Windtree Therapeutics On Thursday Filed Form RW To Withdraw Registration Statement On Form S-1</a>
&nbsp;
COUR: 25% &#x7C; <a href="https://www.benzinga.com//node/39982456">Coursera shares are trading higher after the company beat Q2 earnings estimates.</a>

Movers

Trading Ideas

COUR

CREV

WINT

Market-Moving News for July 26th

Wells Fargo analyst Finian O'Shea maintains Barings BDC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBDC#NYSE">BBDC</a>) with a Equal-Weight and raises the price target from $9 to $9.5.

BBDC

Wells Fargo Maintains Equal-Weight on Barings BDC, Raises Price Target to $9.5

WIIM

Norfolk Southern shares are trading higher after the company reported better-than-expected Q2 earnings results.

Boston Beer Company shares are trading lower after the company reported worse-than-expected Q2 financial results.

RBC Capital analyst Sabahat Khan maintains Waste Connections (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WCN#NYSE">WCN</a>) with a Outperform and raises the price target from $195 to $199.

TSX:WCN

RBC Capital Maintains Outperform on Waste Connections, Raises Price Target to $199

BurgerFi shares are trading higher after the company announced it reached a legal settlement agreement with Lion Point Capital. The company agreed to pay $1,350,000 and issue Lion Point 300,000 of preferred stock.

Wells Fargo analyst Finian O'Shea maintains Bain Capital Specialty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BCSF#NYSE">BCSF</a>) with a Overweight and raises the price target from $17 to $18.

BCSF

Wells Fargo Maintains Overweight on Bain Capital Specialty, Raises Price Target to $18

CLLS

Cellectis shares are trading higher after the company announced the FDA granted orphan drug and rare pediatric designation disease to UCART22.

Mohawk Industries shares are trading higher following mixed Q2 earnings. B of A Securities upgraded the stock from Underperform to Buy.

Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) is making significant strides in artificial intelligence with its homegrown AI chips.
In its Austin, Texas, chip lab, Amazon engineers are rigorously testing a new server design that features these AI chips, aiming to reduce reliance on Nvidia Corp&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) costly chips, Reuters reports.
Amazon&#8217;s efforts align with similar initiatives by rivals Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) and Google parent Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>).
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/06/39463584/nvidia-dominates-gpu-market-as-generative-ai-adoption-grows-analyst-says" rel="noreferrer noopener">Nvidia Dominates GPU Market as Generative AI Adoption Grows, Analyst Says</a>
Rami&nbsp;Sinno, director of engineering for Amazon&#8217;s Annapurna Labs, highlighted the growing customer demand for more affordable alternatives to Nvidia. Annapurna Labs, acquired by Amazon in 2015, is integral to this development.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="750" height="650" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/26042326/newplot-66.png" alt="" class="wp-image-458719" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/26042326/newplot-66.png 750w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/26042326/newplot-66-300x260.png 300w" sizes="(max-width: 750px) 100vw, 750px" /></figure>
Amazon has been developing its Graviton chips, which perform non-AI computing tasks, for nearly a decade. The latest AI chips, Trainium and Inferentia, offer significant cost savings.
&#8220;The offering of up to 40%, 50% in some cases of improved price and performance means it should be half as expensive as running that same model with Nvidia,&#8221; said David Brown, Vice President of Compute and Networking at AWS, according to Reuters.
Sales at AWS, which accounts for almost 20% of Amazon&#8217;s total revenue, grew by 17% to $25 billion in the January-March quarter compared to the previous year. AWS holds approximately one-third of the cloud computing market, with Microsoft&#8217;s Azure at about 25%.
Analysts view Nvidia as the <a target="_blank" href="https://www.benzinga.com/news/24/07/39842530/whats-going-on-with-nvidia-and-amd-stocks-on-thursday" rel="noreferrer noopener">primary beneficiary in</a> the AI sector. Mizuho Securities reports that Nvidia controls 70% to 95% of the market share for artificial intelligence accelerators.
The Big Tech trio—Google, Microsoft, and Amazon—along with Oracle Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>)—contribute more than 40% of Nvidia&#8217;s revenue.
Amazon stock gained over 40% in the last 12 months, reaching a market cap of $1.87 trillion. Nvidia stock surged over 147% in the last 12 months and currently has a market cap of $2.76 trillion. Investors can gain exposure to the stocks through SPDR S&amp;P 500 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and iShares Core S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVV#NYSE">IVV</a>).
Price Action: AMZN shares traded higher by 1.47% at $182.50 premarket at the last check on Friday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo by Sundry Photography via Shutterstock

Tech

Media

AMZN

GOOG

GOOGL

MSFT

NVDA

ORCL

Amazon Tests AI Chips in Texas Lab, Aims to Cut Nvidia Costs

Coursera shares are trading higher after the company beat Q2 earnings estimates.

Wells Fargo analyst Elyse Greenspan maintains RenaissanceRe Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNR#NYSE">RNR</a>) with a Overweight and lowers the price target from $288 to $280.

Wells Fargo Maintains Overweight on RenaissanceRe Holdings, Lowers Price Target to $280

RBC Capital analyst Matthew McKellar maintains West Fraser Timber (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFG#NYSE">WFG</a>) with a Outperform and raises the price target from $97 to $100.

TSX:WFG

RBC Capital Maintains Outperform on West Fraser Timber, Raises Price Target to $100

Keefe, Bruyette &amp; Woods analyst Timothy Switzer reiterates Live Oak Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOB#NYSE">LOB</a>) with a Market Perform and raises the price target from $40 to $47.

Keefe, Bruyette & Woods Reiterates Market Perform on Live Oak Bancshares, Raises Price Target to $47

Norwood Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWFL#NASDAQ">NWFL</a>) reported quarterly earnings of $0.52 per share. This is a 35.8 percent decrease over earnings of $0.81 per share from the same period last year.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Gogox Holdings

News

Latest news for Gogox Holdings (OTC:GGHLF) Stock